Hon CHRIS HIPKINS (Minister for COVID-19 Response): In answer to the question of supply, the short answer to that is no. We are dealing with a significant shortage of rapid antigen tests globally, and whilst New Zealand has been able to secure a supply of rapid antigen tests to meet our immediate needs, of course we would like more. In answer to the second part of the question around the administration of rapid antigen tests in New Zealand, the answer to that question is yes. As I've just noted, we have at least 7.2 million rapid antigen tests currently in the country. Millions more are arriving each week. Twenty-three million rapid antigen tests have been confirmed for delivery by the end of this month. More than 50 million tests have been confirmed for delivery in March. Over 100 million more are on order to the end of June. A national distribution model for rapid tests has also been developed, meaning an estimated 3.1 million tests have been distributed across the country already, in preparation for phase 2. As we move into this new phase, we know that rapid antigen tests will be used more widely, and they'll be a very important tool in our response to Omicron. However, it is important to note that they are not a silver bullet, and we will continue to take a considered and science-based approach towards our use of these tests to ensure that our response is fit for purpose.